Feature Channels: Personalized Medicine

Filters close
Newswise: The pros and cons of radiotherapy: will it work for you?
Released: 30-Mar-2020 8:45 AM EDT
The pros and cons of radiotherapy: will it work for you?
University of South Australia

Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia’s most experienced radiation oncology medical physicists.

Newswise: April's Edition of SLAS Technology is Accessible
Released: 23-Mar-2020 11:35 AM EDT
April's Edition of SLAS Technology is Accessible
SLAS

Just released is the April edition of SLAS Technology featuring cover article, “CURATE.AI: Optimizing Personalized Medicine with Artificial Intelligence,” by Agata Blasiak, Ph.D., Jeffrey Khong, Ph.D., and Theodore Kee, Ph.D., (University of Singapore and The N.1 Institute for Health).

Released: 21-Feb-2020 8:00 AM EST
Coriell Researchers Identify SNP Associated with Obesity Risk
Coriell Institute for Medical Research

Obesity is among the most common complex diseases in the United States and has been a stubborn public health challenge for decades. Its causes are wide ranging, but genetic heritability is increasingly understood to be an influential factor in determining a person’s risk for the disease. Coriell researchers have found a new genetic indicator of obesity risk and bolstered the understood importance of one gene’s role in obesity risk.

Newswise: John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma
Released: 20-Feb-2020 10:55 AM EST
John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma
Hackensack Meridian Health

John Theurer Cancer Center at Hackensack University Medical Center is the only site in New Jersey and one of just 17 in the country participating in a multicenter international Phase II study of an innovative personalized cancer vaccine being evaluated in combination with pembrolizumab immunotherapy in patients with melanoma that has been surgically removed but has a high risk of coming back. The hope is that the vaccine can prime a patient's immune system to be more responsive to immunotherapy and reduce the risk of cancer recurrence.

Newswise: 224618_web.jpg
Released: 19-Feb-2020 11:15 AM EST
Think all BPA-free products are safe? Not so fast, scientists warn
University of Missouri, Columbia

Using "BPA-free" plastic products could be as harmful to human health -- including a developing brain -- as those products that contain the controversial chemical, suggest scientists in a new study led by the University of Missouri and published in the Proceedings of the National Academy of Sciences.

Newswise: Superior “Bio-Ink” for 3D Printing Pioneered
Released: 10-Feb-2020 2:05 PM EST
Superior “Bio-Ink” for 3D Printing Pioneered
Rutgers University-New Brunswick

Rutgers biomedical engineers have developed a “bio-ink” for 3D printed materials that could serve as scaffolds for growing human tissues to repair or replace damaged ones in the body. Their study was published in the journal Biointerphases.

Released: 4-Feb-2020 4:15 PM EST
A New Outline of Cancer Therapies for Patients
American Technion Society

Professor Yuval Shaked, head of the Technion Integrated Cancer Center, presents an outline for therapy that will prevent the development of cancer treatment resistance, with suggestions about how the information can be used clinically.

Newswise: Grant to help UniSA researchers develop personalised cancer treatment
Released: 12-Jan-2020 9:05 AM EST
Grant to help UniSA researchers develop personalised cancer treatment
University of South Australia

Personalised cancer treatment is one step closer to becoming a reality for more patients, thanks to a Cancer Council Beat Cancer Project grant awarded to University of South Australia researcher Dr Stephanie Reuter Lange to explore how computer-based modelling can optimise cancer treatment and remove the need for expensive clinical trials.

Released: 10-Jan-2020 2:25 PM EST
Your Brain: Individual and Unique
American Technion Society

New findings show that individual variations in the brain’s structural connectome (map of neural connections) define a specific structural fingerprint with a direct impact on the functional organization of individual brains.


Showing results

110 of 10

close
0.58086